Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia from the PACE and OPTIC trials Meeting Abstract


Authors: Apperley, J.; Kantarjian, H.; Deininger, M.; Abruzzese, E.; Cortes, J.; Chuah, C.; DeAngelo, D. J.; DiPersio, J.; Hochhaus, A.; Lipton, J. H.; Nicolini, F.; Pinilla-Ibarz, J.; Rea, D.; Rosti, G.; Rousselot, P.; Mauro, M.; Shah, N.; Talpaz, M.; Vorog, A.; Ren, X.; Jabbour, E.
Abstract Title: Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia from the PACE and OPTIC trials
Meeting Title: 10th Annual Meeting of the Society of Hematologic Oncology (SOHO)
Keywords: leukemia; cml; tki; ponatinib; t315i
Journal Title: Clinical Lymphoma, Myeloma and Leukemia
Volume: 22
Issue: Suppl. 2
Meeting Dates: 2022 Sep 28-Oct 1
Meeting Location: Houston, TX
ISSN: 2152-2650
Publisher: Elsevier Inc.  
Date Published: 2022-10-01
Start Page: S284
End Page: S285
Language: English
ACCESSION: WOS:000897948100237
PROVIDER: wos
DOI: 10.1016/s2152-2650(22)01358-1
Notes: Meeting Abstract: CML-046 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael John Mauro
    267 Mauro